Skip to main content
. 2019 Feb 8;98(6):e14400. doi: 10.1097/MD.0000000000014400

Figure 2.

Figure 2

The relative efficacies of PCSK9 inhibitors, statins, ezetimibe, and placebo for improving LDL cholesterol, HDL cholesterol, and total cholesterol level in patients with hypercholesterolemia. Data are presented with standard mean difference and 95% confidence intervals. HDL = high-density lipoprotein, LDL = low-density lipoprotein, PCSK9 = proprotein convertase subtilisin-kexin type 9 serine protease.